INTRODUCTION
The adrenoleukodystrophy protein (ALDP, ABCD1) belongs to the ATP-binding cassette (ABC) transporter protein family. Besides PMP70 (ABCD3) and ALDR (ABCD2) it is one of three ABC half-transporters residing in the peroxisomal membrane of mammals (1) (2) (3) (4) . ALDP has a pivotal role in peroxisome function since mutations in the ABCD1 gene encoding ALDP are responsible for the most common inherited peroxisomal disorder Xlinked adrenoleukodystrophy (X-ALD). This complex and devastating neurodegenerative disorder is characterized by the abnormal accumulation of saturated very long chain fatty acids (VLCFAs) especially in brain white matter, adrenal cortex and testis (5) (6) (7) . To date, 567 pathogenic ABCD1 mutations are known, 357 of these are missense (HGMD database, www.hgmd.org).
They are distributed throughout the gene without a mutational 2 hotspot. 138 of the ABCD1 mutations are associated with a considerable reduction or total lack of the ALDP protein, whereas in the presence of 31 mutations the ALDP protein is detectable. Phenotypic variability in X-ALD is extremely pronounced. One and the same mutation can lead to different disease patterns in patients ranging from the severe childhood cerebral form characterized by fatal progressive demyelination, over adrenomyeloneuropathy and adrenal insufficiency without neurological symptoms to asymptomatic individuals. The pathogenesis of X-ALD as well as the mechanism of function of the peroxisomal ABC halftransporters and their assembly in the peroxisomal membrane are still unsolved, hence, a defect of ALDP alone is not satisfactory to explain the broad range of clinical X-ALD phenotypes. ABC transporters generally consist of two homologous halves, each containing a membrane-spanning domain with multiple hydrophobic transmembrane helices and a hydrophilic cytosolic nucleotide binding fold (NBF) comprising the highly conserved motifs Walker A, Walker B and 19-mer that are important for substrate specificity and nucleotide binding (8) (9) (10) . ABC transporters can either exist as full-size transporters comprising twelve transmembrane helices and two NBFs, e. g. the multiple drug resistance transporter (MDR) (11) and the cystic fibrosis transmembrane regulator (CFTR) (12) , or as half-transporters with only six transmembrane helices and one NBF. ALDP, PMP70 and ALDR belong to the group of half-transporters implying that their functionality depends on dimerization. It was previously demonstrated that ALDP and PMP70 can form homodimers as well as heterodimers with other peroxisomal ABC half-transporters (13) (14) (15) (16) . ALDP as a homodimer is able to transport VLCFAs, most probably VLCFA-CoAs, from the cytosol into the peroxisomal lumen for β-oxidation as demonstrated in yeast (17) . PMP70 seems to be responsible for the import of long chain fatty acids, branched chain acyl-CoAs as well as intermediates of bile acid synthesis into the peroxisomal lumen (18, 19) . In Drosophila the uptake of precursors for the synthesis of red and brown pigments that determines eye color is controlled by various combinations of the ABC half-transporters scarlet, brown, and white, respectively (20) . It remains to be elucidated whether the formation of different ABC full-size transporter subspecies in Homo sapiens has any influence on the transported substrates. All three peroxisomal transporters are synthesized on free ribosomes in the cytosol and then are inserted in the peroxisomal membrane. Localization of the ABC transporters to the peroxisomal membrane is mediated by interaction with PEX19 via a targeting motif at the N-terminal part of the ABC transporters (21, 22) . In order to bring light into the role of these transporters in the peroxisome membrane and thus the pathogenesis of X-ALD, we searched for new interaction partners of ALDP and PMP70. We identified positive protein-protein interactions (PPI) of ALDP, PMP70, ACLY, ACC, FASN and FATP4 by use of GST pull-down experiments followed by mass spectrometry (LCMS), co-immunoprecipitation assays as well as bioluminescence resonance energy transfer (BRET) measurements. A more detailed characterization of these interactions revealed a stratified interaction pattern with varying relative binding affinities among different protein pairs. These findings are in line with potential protein complexes of alternating composition that might be adjusted to different metabolic needs or pathways. As these proteins are involved in sequential steps of lipid metabolism our findings are in line with a novel fatty acid synthesis-transport machinery located at the peroxisomal membrane.
EXPERIMENTAL PROCEDURES

Plasmids constructions
All cDNA fragments were amplified from human cDNA using Pfu-Polymerase (Promega). Sequences of the oligonucleotides used for plasmids constructions are listed in Supplementary Table 5 . To amplify GST-C-ALDP (aa 357-745), oligonucleotides "C-term. ALDP for.2" and "ALDPStop-NotI rev" were used. For GST-C-PMP70 (aa 339-659), oligonucleotides "C-term. PMP70 for" and "PMP70NotI" were used. GST-C-ALDP and GST-C-PMP70 were cloned into pGEX-6P-2 (GE Healthcare). EYFP-ALDP (aa 1-745) was amplified using oligonucleotides "ALDP up" and "ALDP down" and the amplification product was cloned into pEYFP-C1 vector (Clontech). ECFP-PMP70 (aa 1-659) was cloned into pECFP-C1 vector (Clontech) after amplification with primers "PMP70 up" and "PMP70 down". For FATP4myc
oligonucleotides "FATP4myc for" and "FATP4myc rev" were used and the product was cloned into pcDNA 
GST Pull-down Assays
GST fusion proteins and GST were produced in E. coli BL21 cells (Stratagene). 3 hours after induction with 1mM isopropyl β-Dthiogalactoside at 30°C, cells were harvested, resuspended in cold PBST plus protease inhibitors (Roche) and lysed by sonication. Lysis was enhanced by freezing and thawing. GST and fusion protein lysates were clarified by centrifugation (18000 g, 30 minutes, 4°C). Supernatants were incubated with a 50% Glutathione-Sepharose 4B slurry (GE Healthcare).
Recombinant proteins immobilized to the sepharose beads were incubated with HeLa cell lysates at 4°C over night. HeLa cell lysate was prepared from 8 confluent 10 cm plates. Per plate 1 ml lysis buffer (120 mM NaCl, 50 mM Tris pH 7.5, 1 mM EDTA, 0.1% NP-40, 0.1% Triton X-100, protease inhibitors) was used. Cell lysates were prepared by homogenization on ice followed by centrifugation (14000 g, 10 minutes, 4°C). After overnight incubation with HeLa cell lysate, beads were washed 3 times with lysis buffer. Bound proteins were eluted by heating at 95°C in SDS sample buffer and visualized in SDS-PAGE by colloidal Coomassie staining.
Protein identification, LCMS
The tryptic in-gel digestion was performed according to Shevchenko (23) Emitter FS360-20-10 (New Objective). For LCMS 10 µl sample were loaded on a µ-Precolumn TM Cartrige and washed for 8 min at a flow of 30 µl/min. The gradient nano-flow (200 nl/min) transferred the peptides to the analytical capillary column. A solvent gradient from 5% B (84% acetonitrile, 16% water, 0.07% formic acid) to 50% B within 40 min was applied. Columns were cleansed with 95% B followed by pre-equilibration (5% B). Peptides eluting during the 40 min gradient were online transferred to MS by electrospray ionization (ESI) through the use of a PicoTip TM emitter and a spray voltage of 1.5 kV. During the LC gradient the mass spectrometer cycled through the acquisition of a full MS scan within the mass range from 300 to 1400 Da followed by four data-dependent collisioninduced MS/MS spectra of the four most intense ions. The dynamic exclusion was set at exclusion mass width ± 3 Da, repeat count 2, repeat duration 0.5 min, exclusion list size 50, exclusion duration 1 min. Spectra were collected in centroid mode. MS2 spectra analysis was done with the BioworksBrowser 3.3.1 package using the NCBI non-redundant database.
Search parameters for TurboSEQUEST were (i) precursor ion mass tolerance less than 1.4 amu, (ii) fragment ion mass tolerance less than 1.0 amu, (iii) up to three missed tryptic cleavages allowed, and (iv) fixed cysteine modification by carboxyamidomethylation (plus 57.05 amu) and variable modification by methionine oxidation (plus 15.99 amu). Matching peptides for protein identification had to pass the following filters (i) cross-correlation scores (Xcorr) over 2.5, (ii) P-value below 5.0E-02; and (iii) the primary scores (Sp) at least 500. 
Cell Culture and transient transfection
10
6 cells were seeded. Cells were transiently transfected with DNA coding for the indicated proteins using Effectene transfection reagent (Qiagen). HEK293 cells were cultured in Hyperflask cell culture vessels (Corning) in DMEM high glucose (4.5 g/l) (PAA) supplemented with 10% fetal calf serum, 100 units/ml penicillin, 0.1 mg/ml streptomycin, and 0.25 µg/ml amphotecerin B. For BRET measurement transfection based on electroporation was performed in a 96-well format using the Amaxa 96-well shuttle system (Lonza).
Co-immunoprecipitation and immunoblotting (Western blotting)
HeLa cells were grown in 10 cm plates, cells from 6 plates per condition were harvested and transiently transfected with indicated DNA constructs. Twenty-four hours post transfection cells were lysed in 500 µl Co-IP lysis buffer per plate (150 mM NaCl, 20 mM Tris pH 7.5, 1 mM EDTA, 1% Triton X-100, protease inhibitors) by homogenization followed by a freeze and thaw cycle. Lysates were clarified by centrifugation (18000 g, 10 minutes, 4°C). Half of the supernatant was rotary incubated overnight at 4°C with antibodies as indicated, i. e. anti-GFP (JL8, Clontech, 1:50), anti-FASN (Cell Signaling, 1:50) or anti-myc (Cell Signaling, 1:1000). The remaining half served as a control and was incubated without antibody. The next day 50 µl protein A/G PLUS-agarose (Santa Cruz Biotechnology) were added for 2 hours. After 5 washing steps with Co-IP lysis buffer, precipitated proteins were eluted by heating at 95°C in SDS sample buffer and analyzed by Western blotting. Proteins separated by SDS-PAGE were transferred to nitrocellulose membranes using blotting buffer (48 mM Tris-HCl, 39 mM glycine, 0.04% w/v SDS, 20% methanol). Membranes were blocked in TBST + 5% defatted milk followed by overnight incubation at 4°C with primary antibodies as indicated, i. e. anti-GFP (JL8, Clontech, 1:1000), anti-ACLY (Cell Signaling, 1:1000), anti-FASN (Cell Signaling, 1:1000), anti-myc (Cell Signaling, 1:1000), anti-ALDP (2B4, Euromedex, 1:1000). Incubation with appropriate secondary HRP-labelled antibody was followed by detection with Lumi-Light Western blotting substrate (Roche).
Immunofluorescence staining
HeLa cells were seeded on glass coverslips. For immunofluorescence cells were washed with PBS and fixed with 4% paraformaldehyde solution for 15 minutes. After 3 washing steps with PBS, cells were permeabilized with PBS supplemented with 1% (v/v) Triton X-100 for 5 minutes. After 3 washing steps with PBS primary antibodies were added for 1 hour (polyclonal anti-FASN, Cell Signaling, 1:50; monoclonal anti-ALDP, 2B4 Euromedex, 1:1000). After washing 3 times with PBS secondary antibodies were added for an additional hour (anti-mouse-488, Molecular Probes, 1:1000; anti-rabbit-Cy3, Jackson Immuno Research, 1:1000). After three final washing steps with PBS, cells were mounted using ProLong Gold (Invitrogen) and examined using a confocal microscope.
BRET measurements
The binary interaction of proteins in living cells was analyzed using bioluminescence resonance energy transfer (BRET) as described before (24) . Interactions were tested in all eight possible combinations of the proteins either fused to Rluc (energy donor) or YFP (energy acceptor). All combinations were tested in duplicates and two independent experiments. HEK293 cells were cotransfected with a total of 0.8 µg of DNA at acceptor to donor ratios of 3:1 and incubated at 30°C. BRET saturation experiments to determine the maximal BRET ratio (BRET max ) and relative binding affinity (BRET 50 ) were performed as described before (24) . Cells were co-transfected with indicated DNAs, respectively with increasing acceptor to donor ratios, keeping the total DNA amount at constant level. After 48 hours 30 µM coelenterazine was added as the Rluc substrate and light emission was collected in a 96-well microplate luminometer LUMIstar OPTIMA (BMG Labtech) over 10 seconds at 475 nm (Rluc signal) and 535 nm (BRET signal). The signals were analyzed by calculation of the BRET-ratio based on equation 1,
where R is the BRET ratio, I A is the intensity of light emission at 535 nm, I D is the intensity of light emission at 475 nm, and cf is a correction factor = (BRETcontrol/Rluccontrol) with the negative control being the cotransfection of donor fusion-protein with YFP in the absence of the protein of interest. A positive interaction of two investigated protein pairs was assumed, if at least 1 out of 8 tested tag combinations results in a BRET ratio above an experimentally derived method-specific threshold of 0.094. A positive control interaction (bJun-bFos) and the expression of Rluc-YFP as a positive control construct were included in every individual experiment. In addition, negative controls analyzing the interaction of ALDP with putatively noninteracting proteins (IL10RB, ACADS) were performed (Supplementary Table 2 ). PPI parameters were calculated by Y = BRETmax * (X/BRET50+X), where BRETmax is the maximal BRET ratio and BRET50 is the acceptor to donor ratio required to reach half-maximal BRET, indicating the relative binding affinity of protein-protein interaction partners.
RESULTS
Identification of novel interaction partners of ALDP and PMP70
To identify novel interaction partners, we performed GST pull-down experiments with recombinant ALDP and PMP70. Since the Nterminal halves of both proteins are inserted into the peroxisomal membrane and therefore are highly hydrophobic, we expressed the hydrophilic cytoplasmic parts of both transporters in E. coli (aa 357-745 of ALDP and aa 339-659 of PMP70) as GST fusion proteins. Purified GST-C-ALDP and GST-C-PMP70 or GST as a control were coupled to glutathione sepharose and incubated with lysates of HeLa cells ( Figure 1A ). To ensure specific binding of proteins from the cell lysate to C-ALDP or C-PMP70 pull-down experiments were compared to GST alone or to the corresponding GST fusion proteins, which were not incubated with cell lysate. Protein bands at 67 kDa and 62 kDa represent GST-C-ALDP and GST-C-PMP70 fusion proteins, respectively. Protein bands not present in control lanes were excised, trypsin digested and analyzed by LCMS. For the most prominent band of the C-ALDP pull-down at around 120 kDa many high scoring peptides belonging to ATP-citrate lyase (ACLY) were found giving a total SEQUEST protein score of 266. In addition, a C-PMP70 specific band of more than 200 kDa that was not present in control lanes could be identified as fatty acid synthase (FASN) with a SEQUEST protein score of 238 (see Supplementary Table 1 showed that these tags either both at the Nterminal and at the C-terminal side of the transporters do not hamper the import into the peroxisomal membrane (16, 25) . ACLY and FASN were detected by specific antibodies in the respective immunoblots after overexpression of EYFP-ALDP and ECFP-PMP70 in HeLa cells and precipitation with anti-GFP ( Figure 1B ). These data substantiated the physical interaction of ALDP with ACLY as well as PMP70 and FASN and showed that full-length ABC transporters properly sorted to the peroxisomal membrane can form complexes with their endogenously expressed binding partners. Immunofluorescence costaining of ALDP and FASN was performed in HeLa cells to determine co-localization of the endogenous proteins (Figure 1 E) . ALDP (green) shows a punctate peroxisomal staining pattern, whereas FASN (red) shows a ubiquitous staining throughout the cell. Colocalization of FASN with peroxisomes (yellow) supported the physical interaction of FASN with peroxisomal ABC-transporters. To confirm PPI found by GST pull-down and co-immunoprecipitation studies, BRET experiments were performed testing binary interactions in vivo in the living cell. We conducted a PPI mini screen, probing all possible heteromeric and homomeric interacting pairs of ALDP, PMP70, FASN and ACLY including previously described homoor heterooligomerizations and potential further interactions. HEK293 cells were co-transfected with constructs of the respective genes carrying N-or C-terminal tags of Renilla reniformis luciferase (Rluc) as the donor or yellow fluorescent protein (YFP) as the acceptor of energy transfer (Supplementary  Table 2 ). For all heteromeric and homomeric protein pairs tested, at least one out of eight possible tag combinations resulted in BRET ratios above the method-specific threshold for a positive PPI of 0.094 ( Figure 1C) . Thus, these data confirmed the interactions of ALDP-ACLY (BRET ratio 0.14) and PMP70-FASN (0.11) identified by GST pull-down and coimmunoprecipitation.
Furthermore, they support the previously reported homo-and heterooligomerization of ALDP and PMP70 (ALDP-ALDP, 0.51; PMP70-PMP70, 0.11; ALDP-PMP70, 0.12) as well as the known homooligomerization of ACLY (0.42) and FASN (0.11). Beyond that, BRET experiments identified positive interactions for ALDP with FASN (0.10) and for PMP70 with ACLY (0.39). These data pointed to the formation of a heteromeric complex of ABC-transporters with FASN and ACLY, that was further substantiated by a positive interaction of FASN with ACLY (0.17).
In conclusion, our data revealed novel interactions of the ABC half-transporters ALDP and PMP70 with ACLY and FASN and confirmed known homooligomerization of all proteins tested. The observation of mutual interactions of ALDP, PMP70, FASN and ACLY ( Figure 1D ) gave rise to the hypothesis that varying ternary or quaternary complexes of different functionally active dimeric ABC full-size transporters (ALDP-ALDP, PMP70-PMP70, ALDP-PMP70) and FASN-ACLY, respectively, could be formed.
Characterization of protein complex architectures by BRET saturation experiments
In a previous study, we demonstrated by means of live cell FRET microscopy in vivo, that ALDP and PMP70 form homodimers as well as ALDP-PMP70 heterodimers, where ALDP homodimers displayed highest values followed by PMP70-PMP70 and ALDP-PMP70, respectively (16) . In this study, interactions of both half-transporters (ALDP and PMP70) with FASN and ACLY were found. In order to characterize the architecture of these potential complexes, we first aimed to approximate the likelihood for formation of different complexes by determination of the relative binding affinity. Second, we investigated their structural conformation by BRET-based distance measurements. BRET saturation experiments were performed (Figure 2,  Supplementary Table 3) , where the relative binding affinity index can be determined by use of the ratio (acceptor/donor ratio) of proteins carrying the energy acceptor (YFP) to proteins carrying the energy donor (Rluc) at half-maximal BRET (BRET 50 ). For proteins with comparable structure the maximum BRET ratio (BRET max ) can be taken as a measure of the relative orientation of the tags to each other and hence give information about differences in protein conformation. The analysis of the relative binding affinity of ALDP and PMP70 to form homo-and heterooligomers ( Figure 2A) showed that ALDP has a significant higher affinity (P < 0.01) to form homooligomers (BRET 50 , 0.85) than to form heterooligomers with PMP70 (BRET 50 , 2.05). This is in line with the observations obtained by FRET (16) . In addition, the data may suggest that PMP70 has a comparable affinity to homooligomerize (BRET 50 , 1.22) and is more likely to exist as a homooligomeric than as a heterooligomeric transporter (this difference was statistically not significant). Conformational analyses by BRET max resulted in higher values for PMP70-PMP70 and ALDP-PMP70 as compared to ALDP-ALDP (Figure 2A complexes involved in the synthesis and transport of fatty acids at the peroxisomal membrane ( Figure 2C ). In theory, all combinations of ALDP, PMP70, FASN and ACLY are possible. However, the likelihood for the formation of a quaternary complex composed of a heteromeric ABC-transporter and FASN-ACLY is rather low. Ternary complexes formed by homomeric ABCtransporters and FASN-ACLY would be of similar structure, but the abundance of ACLY in the ALDP-ALDP based complex is of lower likelihood than for the PMP70 based complex.
Association of ACC1 with the newly identified protein complex
Since Acetyl-CoA carboxylase 1 (ACC1) as malonyl-CoA provider is the enzyme that functionally lies between ACLY and FASN in de novo fatty acid synthesis ( Figure 3A) , we raised the hypothesis that ACC1 may also associate with the newly identified complex. Thus, we investigated the binary interaction of ACC1 with ALDP, PMP70, ACLY, FASN and FATP4, by BRET analysis. Co-transfection of ACC1 with ACLY resulted in BRET ratios above the method-specific threshold for a positive PPI of 0.094 in two out of eight possible tag combinations, with the highest BRET ratio (0.19) detected in cells coexpressing ACC1-Rluc and ACLY-YFP. However, co-expression of ACC1 with ALDP, PMP70, FASN, or FATP4 did not result in positive BRET ratios ( Figure 3B ). These data indicate that ACC1 interacts with ACLY, but not with ALDP, PMP70, FASN, or FATP4. Moreover, cells coexpressing ACC1 carrying N-terminal tags of Rluc and YFP resulted in strong BRET signals with a BRET ratio of 0.1. This finding supports the previously reported homooligomerization of ACC1.
Identification of FATP4 as a new interaction partner of the ABCD-ACLY-FASN complex
The members of the identified PPI network could provide acetyl-CoA as the building block for fatty acids (ACLY), malonyl-CoA (ACC1), long-chain fatty acid synthesis (FASN) and transport of CoA-activated fatty acids across the peroxisomal membrane (ALDP or PMP70). Therefore, we searched for the missing link in the complex that may carry out this activation step ( Figure 3A) . Fatty acid transport protein 4 (FATP4) was identified as the main VLCFA acyl-CoA synthetase that localizes to the peroxisome and to other organelles (27) . In order to analyze the association of FATP4 with components of the ABCD-ACLY-FASN complex, we performed co-immunoprecipitation and BRET experiments. FATP4myc was overexpressed in HeLa cells and endogenous ALDP or co-overexpressed ECFP-PMP70 were tested for co-precipitation, respectively ( Figure 3C Table  2) . Furthermore, we showed that FATP4 binds to FASN (mean 0.10) and that FATP4 has the capacity to form homooligomers (mean 0.19). However, FATP4 did not show a positive PPI with ACLY (mean 0.08). Taken together, FATP4 is part of a PPI-network ( Figure 3E ) of proteins involved in synthesis, activation and transport of fatty acids at the peroxisomal membrane. The interaction pattern found indicates that FATP4 forms a complex with an ABC full-transporter and FASN. In addition, ACLY is associated via an interaction with PMP70 or, to a lesser extent, with ALDP.
Identification of a new fatty acid synthesistransport machinery at the peroxisomal membrane
The network of ABC-transporters, ACC1, ACLY, FASN and FATP4 supports the existence of a fatty acid synthesis-transport machinery providing activated fatty acids for peroxisomal β-oxidation ( Figure 4A synthesized by FASN (step 2) can be activated by FATP4 to their CoA esters (step 3) and then among other routes be transported by ALDP and/or PMP70 across the peroxisomal membrane into the peroxisome (step 4) for consecutive β-oxidation in the peroxisomal matrix. In addition, ACC1 is associated with ACLY and provides malonyl-CoA as second building block for de novo fatty acid synthesis. ACC1 is not cross-interacting with the other members of the complex and is thus rather associated to than integral part of the protein complex described. Based on our data derived from BRET saturation experiments, we propose a model of the newly identified complex existing in at least three different compositions with the ALDP homooligomer, the PMP70 homooligomer, or the ALDP-PMP70 heterooligomer in combination with ACLY and FASN, respectively. In an attempt to link the fatty acid synthesistransport machinery to the cellular interactome, we performed a database analysis (HPRD and BioGRID database) with subsequent manual recuration (Supplementary Table 4 ) and identified 20 primary PPI ( Figure 4B ). The interacting proteins can be assigned to four different functional entities, i. e. peroxisomal, other organelles, fatty acid metabolism, or cell cycle and signaling pathways.
Impact of mutations in the ABCD1 gene on protein-protein interactions between ALDP and the members of the fatty acid synthesistransport machinery
If a mutation leads to total lack of the corresponding protein, all interactions of this protein will be erased (node removal). In the presence of residual protein, a mutationinduced modification or disruption of single PPI can occur (edgetic perturbation). We analyzed, whether 5 missense mutations in the ABCD1 gene known to be associated with near-normal ALDP protein amounts (G116R, S514N, G607D, G629H, T693M) would induce edgetic perturbations by altering ALDP homooligomerization or the interaction of ALDP with FASN, ACLY or FATP4 ( Figure  5 ). Two mutations, S514N and G629H, led to a reduction of the BRET ratio related to ALDP homooligomerization. Conversely, S514N and G607D increased the BRET ratio for the interaction of ALDP with FASN, while G116R had the same effect on the interaction between ALDP and ACLY. The interaction between ALDP and FATP4 was not affected by any of the mutations. Taken together, missense mutations in the ABCD1 gene can induce edgetic perturbations of the PPI relevant to the fatty acid synthesistransport machinery at the peroxisomal membrane described here ( Figure 5B ).
DISCUSSION
Since loss of the biological function of ALDP alone is not sufficient to explain the onset of demyelination and the broad spectrum of disease severity in X-ALD, it is highly likely that a set of other proteins modulates disease expression. To bring light into this, we searched for interaction partners of this ABCtransporter. Using a combined approach of GST pull-down, co-immunoprecipitation and BRET, we identified a protein complex consisting of two peroxisomal ABC halftransporters (ALDP or PMP70) interacting with the fatty acid metabolism enzymes ACC1, ACLY, FASN and FATP4. Applying GST pull-down and co-immunoprecipitation experiments, we demonstrated interactions of ALDP with ACLY and FATP4 as well as interactions of PMP70 with FASN and FATP4, respectively. To circumvent potential interferences with solubilization procedures that may disrupt PPI or promote interactions that are not present in the physiological cell context, we performed BRET measurements in intact living cells. This led to the confirmation of the already wellestablished homo-and heterodimerization of ALDP and PMP70. Furthermore, we substantiated PPI of ALDP and PMP70 with ACLY and FASN identified by pull-down and co-immunoprecipitation experiments in this study, respectively, as well as the known heterooligomerization of ACLY and FASN. The identification of a binary PPI network of the homomeric ABC full-transporters ALDP and PMP70, or a heteromeric combination thereof, with ACLY and FASN indicated the formation of a protein complex. ACLY catalyzes the formation of acetyl-CoA from citrate and CoA and thus provides the first building block for de novo lipid synthesis (28, 29) . FASN is a multifunctional enzyme that performs seven sequential reactions to convert acetyl-CoA and malonyl-CoA to palmitate (30) (31) (32) . The fact that ACLY and FASN are both known to act in the cytoplasm points to the assembly of this complex at the cytoplasmic side of the peroxisomal membrane. This was substantiated by the observation that the cytoplasmic parts of both PMP70 and ALDP interact with ACLY and FASN. In addition, ACC1 was shown to interact with ACLY, but not with PMP70, ALDP or FASN. From these results we deduced the existence of a fatty acid synthesis-transport machinery composed of ACLY and FASN and either an ALDP homooligomer, a PMP70 homooligomer or a PMP70-ALDP heterooligomer. Since it was proposed that ALDP and PMP70 transport fatty acids of different chain lengths into the peroxisome (17) (18) (19) , varying compositions of the machinery may be responsible for different synthesis and transport pathways, e. g. for fatty acids of different chain lengths or classes. Moreover, the observation of different binding affinities of the proteins to each other revealed that the likelihood for the occurrence of the single complex compositions differs. The ABC transporter within the complex is mainly composed of ALDP or PMP70 homooligomers, which is consistent with reports from earlier studies (16) . However, we again confirmed that ALDP has also the capacity to bind PMP70 in vivo. So far, mutations in the PMP70 gene have not been associated with X-ALD (33). However, it has been proposed that PMP70 influences the inflammatory phenotype in X-ALD (34) . Furthermore, overexpression of PMP70 in X-ALD fibroblasts corrects VLCFA β-oxidation (35) . This raises the hypothesis that PMP70 transporters partially take over the functions of ALDP transporters in X-ALD and that ACLY therefore may have an impact on the course of the disease. As heterodimerization of ALDP with PMP70 might allow for the transport of fatty acids of different chain lengths, the formation of the ALDP-PMP70 heterotransporter may attenuate the clinical phenotype in patients with ALDP deficiency, where an ALDP-PMP70 transporter has a better function than the mutated ALDP-ALDP transporter. It may be conceivable that a varying proportion of homoand heterotransporters in individual patients contributes to the high phenotypic variability observed in X-ALD patients. Interestingly, ACLY is more likely to associate with the PMP70 than with the ALDP transporter in the complex, even though ALDP homodimers have been described to predominate (16) . The complex occurring with the lowest probability would be ALDP-PMP70-FASN-ACLY, indicating that its formation is rare, but possible. We showed that ALDP and PMP70 bind FASN with comparable affinity. Thus, the synthesis of fatty acids by FASN might be closely linked to the transport of the respective VLCFA and LCFA into the peroxisome by both, the homoand heteromeric ALDP/PMP70 transporters. It is of note that BRET experiments for FASN were exclusively performed using the Cterminal thioesterase domain (BC007909). This demonstrates that beyond the interdomain region (36) , the thioesterase domain on one hand has the capacity to self-associate and on the other hand may be involved in establishing the interactions inside the PPI network. Furthermore, the interaction of ALDP with ACLY and FASN is of special interest in view of the involvement of the latter proteins in lipid metabolism of myelin formation and integrity and thus brain functions, which are impaired in patients with X-ALD. Studies involving heterozygous ACLY knockout mice showed high ACLY expression in neural tube and brain during development and in glial cells and cholinergic neurons in adult mice (37) . Palmitate synthesized by FASN can be elongated to VLCFAs that are components of ceramides, sphingolipids and glycerolipids needed for brain development including myelination, neurological functions and cell signaling (38) . Moreover, we showed that ACC1 and the acylCoA synthetase FATP4 are associated with the protein complex identified here. ACC1 carboxylates acetyl-CoA to malonyl-CoA, the second building block for lipid synthesis by FASN. FATP4 is a member of the family of fatty acid transporters (39) and transports LCFAs and VLCFAs. In addition, FATP4 is capable of activating both LCFAs and VLCFAs to their CoA derivatives (26,(40,41) . However, elongation of LCFAs is catalyzed by the fatty acid elongase machinery, an endoplasmic reticulum bound enzyme complex (42) . Thus, ACC1 and FATP4 constitute the missing links in this multi-modal unit of fatty acid synthesis and transport, providing metabolites for FASN enzymatic action as well as transesterification of its product to acyl-CoA for subsequent transport across the peroxisomal membrane. FATP4 interacts with three members of the complex, namely ALDP, PMP70 and FASN, but not with ACLY. These PPI imply that FATP4 is needed to activate fatty acids synthesized by FASN, which then are transported by ALDP and/or PMP70 across the peroxisomal membrane into the peroxisomal matrix for subsequent β-oxidation. Interesting findings with respect to FATP4 dysfunction inside the complex arise from experiments carried out in skin cells lacking FATP4 (43) . Here, the activation of signaling pathways, where most probably accumulated free unesterified fatty acids served as ligands, triggered STAT3 and cytokines leading to upregulation of STAT3 targets by EGFR signaling. The connection of ACC1 to the complex is restricted to a single PPI with ACLY. Both, ACC1 and ACLY provide the building blocks for fatty acid synthesis by FASN and, with respect to a directed functional sequence of the machinery described, could be classified as the rawmaterial supply unit. This unit is linked to the central fatty acid synthesis enzyme FASN, but only loosely connected to the transport unit at the end of the functional sequence (FATP4 and ABC-transporters). These findings together with the notion of similar structural conformations of the ternary complexes, as indicated by comparable BRET 50 values of individual PPI, direct to an intended and not to an accidental occurrence of the complex in evolution. Mutation induced alterations in protein conformation and/or abundance of ALDP at the peroxisomal membrane are expected to impair the formation and function of the newly identified fatty acid synthesis-transport machinery, which may have an influence on the clinical course of X-ALD patients. To verify this hypothesis, we analyzed the effect of five disease-causing missense mutations in the ABCD1 gene on the PPI supposed to be crucial for the formation and function of the protein complex. The impact of mutations on protein complexes or higher order interaction networks can be determined with respect to the abundance of the affected proteins (nodes) and to the ability of the nodes to establish interactions (edges). We showed that three of these mutations, G116R, S514N and G607D, induced edgetic perturbations of PPI by exerting partly countervailing effects on ALDP homooligomerization and the interaction between ALDP and FASN and ALDP and ACLY, respectively. This confirmed that mutations can alter the ALDP interaction network, a mechanism that is expected to contribute to the phenotypic variability in X-ALD patients. However, it has to be taken into account, that the majority of ABCD1 gene mutations is associated with a total lack of ALDP. In these cases, the mutation induces a loss of all interactions with this protein, a process called node removal that would lead to even more deleterious consequences on formation and function of the fatty acid synthesis-transport machinery and in turn on metabolic function in X-ALD patients ( Figure  5B ). As cellular functions are mediated through complex systems of macromolecules and metabolites linked through biochemical and physical interactions, disease-causing mutations may also affect entire systems or interactome properties (44) . In this context, altered interactions with further proteins associated to this network may have an impact on other metabolic or signaling pathways. To address this issue, we linked the fatty acid synthesis-transport machinery to the cellular interactome and identified 20 PPI with proteins involved in four different functional entities (peroxisomal, other organelles, fatty acid metabolism, or cell cycle and signaling pathways). Besides the interaction of ALDP and PMP70 with PEX19 essential for cellular housekeeping of peroxisomal function, heterooligomerization of these ABC halftransporters with ALDR points to the potential existence of further ABC full-transporter subspecies. In view of the hypothesized variation in the composition of complexes described here, this may expand the cellular set of different fatty acid synthesis-transport machineries available for specific metabolic conditions. The PPI of PMP70 with MEST (membrane of the endoplasmic reticulum) and CLN3 (lysosomal membrane) represents an interesting link of the fatty acid synthesistransport machinery to disease-relevant lipid metabolism pathways occurring in other cellular organelles. A possible extension of the ALDP-PMP70-ACC1-ACLY-FASN-FATP4 network arises from the interaction of ACLY with AMPKb, a protein kinase that phosphorylates acetyl-CoA carboxylase 1. The biosynthesis of malonyl-CoA by ACC1 linked to the protein complex through a possible PPI would provide the second building block for de novo lipid synthesis. All other interactions take place with proteins that are involved in processes of cell cycle and cell signaling, e. g. PELO (chromosome segregation), GSK-3b (various signaling pathways), and IKBKE (host defense signaling pathway). The functional impact arising from some of these PPI is in line with and may further extend the relationship of the fatty acid synthesistransport machinery to cell growth and inflammatory processes. Due to the broad spectrum of cellular functions of this interactome, it is most likely that perturbations of one component, e.g. of ALDP in X-ALD, result in remote cellular dysfunctions. Detailed analyses of the pathways involved may in future reveal epigenetic mechanisms linked to the pathogenesis of X-ALD.
In conclusion, we propose a model of ABC full-transporters, ACC1, ACLY, FASN and FATP4 to form a so far unknown peroxisomal fatty acid synthesis-transport machinery. The varying binding affinities of the proteins involved and the hypothesized different substrate specificities of ABC full-transporter subspecies may indicate the existence of alternative complexes for specific demands at fluctuating metabolic needs. Our findings provide new insight into lipid metabolism at a molecular level and contribute novel aspects to the understanding of the pathogenesis in X-ALD. Future work will extend the knowledge on further proteins involved in this process and investigate remote functions of the machinery and its single components.
FIGURE LEGENDS FIGURE 1. The ABC half-transporters ALDP and PMP70 bind ACLY and FASN (A) In two independent GST pull-down experiments recombinant fusion proteins of the C-terminal part of ALDP (GST-C-ALDP, 67 kDa), the C-terminal part of PMP70 (GST-C-PMP70, 62 kDa) or GST alone were incubated with HeLa cell lysates and subjected to Coomassie stained SDS-PAGE. Prominent bands (arrows) present in the GST-C-ALDP or the GST-C-PMP70 pull-down but not in the control (GST alone) were analyzed by LCMS. Of the identified proteins the Sequest probability values and the Sequest protein scores are given (for peptide Xscores see also Supplementary Table 1 ). In GST-C-ALDP pull-down ACLY (120 kDa) was identified as binding partner, in GST-C-PMP70 pulldown FASN (270 kDa) was found. Table 3 ). Data are given as means ± SD of n = 3 independent experiments. The statistical significance of differences between individual BRET 50 and BRET max values was analyzed by ANOVA and refers to the first protein-pair of each individual subgraph (*** P < 0.001; ** P < 0.01; ns, not significant with P > 0.05). www.jbc.org
